HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Treatment of multiple sclerosis with intravenous hydrocortisone hemisuccinate in combination with cyclophosphamide or cytosine arabinoside].

AuthorsW Cendrowski
JournalNeurologia i neurochirurgia polska (Neurol Neurochir Pol) 1974 Jan-Feb Vol. 8 Issue 1 Pg. 47-52 ISSN: 0028-3843 [Print] Poland
Vernacular TitleWstepna próba leczenia chorych na stwardnienie rozsiane dozylnymi wstrzyknieciami hemibursztynianu hydrokortyzonu skojarzonego z cyklofosfamidem lub arabinozydem cytozyny
PMID4407711 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies
  • Cytarabine
  • Cyclophosphamide
  • Hydrocortisone
Topics
  • Adult
  • Antibodies (analysis)
  • Cyclophosphamide (therapeutic use)
  • Cytarabine (therapeutic use)
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hydrocortisone (administration & dosage, therapeutic use)
  • Injections, Intravenous
  • Male
  • Measles (immunology)
  • Middle Aged
  • Multiple Sclerosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: